Determining the magnitude and duration of acute Δ9-tetrahydrocannabinol (Δ9-THC)-induced driving and cognitive impairment: A systematic and meta-analytic review.

Neurosci Biobehav Rev. 2021 Jan 23;:

Authors: McCartney D, Arkell TR, Irwin C, McGregor IS

Abstract
The increasing legal availability of cannabis has important implications for road safety. This systematic review characterised the acute effects of Δ9-THC on driving performance and driving-related cognitive skills, with a particular focus on the duration of Δ9-THC-induced impairment. Eighty publications and 1534 outcomes were reviewed. Several measures of driving performance and driving-related cognitive skills (e.g. lateral control, tracking, divided attention) demonstrated impairment in meta-analyses of « peak » Δ9-THC effects (p’s<0.05). Multiple meta-regression analyses further found that regular cannabis use was associated with less impairment than ‘other’ (mostly occasional) cannabis use (p = 0.003) and that the magnitude of oral (n = 243 effect estimates [EE]) and inhaled (n = 481 EEs) Δ9-THC-induced impairment depended on various factors (dose, post-treatment time interval, the performance domain (skill) assessed) in other cannabis users (p’s<0.05). The latter model predicted impairment would take ∼7 -hs to subside (Hedges’ g=-0.25) after inhaling 20 mg of Δ9-THC; oral Δ9-THC-induced impairment may take longer to subside. These results suggest individuals should wait at least 7 -hs following inhaled cannabis use before performing safety-sensitive tasks.

PMID: 33497784 [PubMed – as supplied by publisher]


Source: ncbi 2

Partage le savoir
Categories: Medical

error: Content is protected !!